Community/Retail

Joseph Saseen, PharmD, FASHP, FCCP, FNLA, BCPS, CLS, talks about what drew him to teach at a pharmacy school.

I hope the pharmacy industry doesn't have to engage in another state-by-state effort to allow the dispensing of appropriate biosimilar products.

NALOXONE ACCESS: A Practical Guideline for Pharmacists will be updated and maintained on the CPNP website as a freely available source of information.

New research validates what pharmacists believe to be true: several disconnects remain in the prescribing and use of opioids.

Bob Davis, PharmD, FAPhA, a professor of the Kennedy Pharmacy Innovation Center, reflects on his 40-year career.

The FDA today approved the first spray-dried fibrin sealant to be used to control bleeding during surgery.

NACDS also urges comprehensive approach to curbing prescription drug abuse that also ensures patient access.

Bob Davis, PharmD, FAPhA, a professor of the Kennedy Pharmacy Innovation Center, talks about the economic benefits of Chronic Care Management programs.

David Nau, PhD, RPh, FAPhA, president of Pharmacy Quality Solutions, talks about what the goals Pharmacy Quality Solutions and its EQuIPP system has with its collaboration with Prime Therapeutics.

Mary M. Bridgeman, PharmD, BCPS, CGP, clinical associate professor in the Department of Pharmacy Practice and Administration at the Ernest Mario School of Pharmacy at Rutgers, details some lesser known facts about some allergic rhinitis treatments.

David Nau, PhD, RPh, FAPhA, president of Pharmacy Quality Solutions, talks about how pharmacies can improve quality of services.

Mary M. Bridgeman, PharmD, BCPS, CGP, clinical associate professor in the Department of Pharmacy Practice and Administration at the Ernest Mario School of Pharmacy at Rutgers, talks about what patients need to know about novel sublingual therapies for the treatment of allergic rhinitis.

Carmela Avena-Woods, BSPharm, PharmD, CGP, assistant clinical professor of clinical pharmacy practice in the College of Pharmacy and Health Sciences at St. John's University, talks about what the teach-back method is and the pharmacist's role in patient counseling.

Mary M. Bridgeman, PharmD, BCPS, CGP, clinical associate professor in the Department of Pharmacy Practice and Administration at the Ernest Mario School of Pharmacy at Rutgers, details some important patient education points for pharmacists.

Carmela Avena-Woods, BSPharm, PharmD, CGP, assistant clinical professor of clinical pharmacy practice in the College of Pharmacy and Health Sciences at St. John's University, talks about some common patient errors in using inhalers and what important usage guidelines pharmacists should share with patients.

The FDA today expanded the indication of fluticasone furoate/vilanterol (Breo Ellipta) for the treatment of asthma.

Here is a blueprint for professional success.

To start your introspective career journey, ask yourself these deceptively simple questions.

Next year's federal defense authorization bill approved today by the House Armed Services Committee includes a proposal to pilot a "preferred" retail pharmacy network for Tricare beneficiaries.

Isavuconazonium sulfate (Cresemba) is now available to treat 2 rare yet life-threatening fungal infections.

The FDA today cleared a first-of-its-kind pregnancy test that can determine a woman's pregnancy status by analyzing her blood.

Allow me to tell you a tale of 2 health care systems, 1 for-profit and 1 non-profit.

A wrecked and looted CVS pharmacy in Baltimore signifies the scale of the riots driven by the death of Freddie Gray.

Jeff has served as Interim CFO since December 2014, while overseeing Investor Relations.

Mary M. Bridgeman, PharmD, BCPS, CGP, clinical associate professor in the Department of Pharmacy Practice and Administration at the Ernest Mario School of Pharmacy at Rutgers, describes the general treatment approach for allergic rhinitis.

Here are the key points and rationale behind the lower blood pressure target.

Bob Davis, PharmD, FAPhA, a professor of the Kennedy Pharmacy Innovation Center (KPIC), talks about what would make KPIC's Chronic Care Management program even more sustainable.

Adults with moderate-to-severe fat under their chin will soon have a new treatment option with today's FDA approval of deoxycholic acid.

The reference is widely used by student pharmacists and practitioners alike.